Hospitals and health systems understand the importance of making health care more affordable for everyone and they “have been tackling the issue head on, taking steps to redesign care and implement operational efficiencies,” AHA told Sen. Lamar Alexander, R-Tenn., in response to a letter seeking input on reducing health care costs.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA's comment on the Food and Drug Administration’s draft guidance on blood glucose monitoring test systems for prescription point-of-care use.
AHA urges the Senate to co-sponsor the Resident Physician Shortage Reduction Act of 2019
(S. 348), a bipartisan bill, authored by Senators Menendez, Boozman and Schumer, that would
increase the number of Medicare-funded residency positions by 15,000 over five years,
thereby helping to alleviate physician shortages that threaten patients’ access to care.
Surprise bills can cause patients stress and financial burden at a time of particular vulnerability: when they are in need of medical care. Patients are at risk of incurring such bills during emergencies, as well as when they schedule care at an in-network facility without knowing the network status of all of the providers who may be involved in their care. We must work together to protect patients from surprise bills.
AHA comments on the CMS proposed Notice of Benefit and Payment Parameters for 2020.
AHA letter to Congressional leaders requesting a delay the start of the Medicaid disproportionate share hospital cuts, scheduled to begin in fiscal year (FY) 2020.
AHA writes to urge the Centers for Medicare & Medicaid Services to consider alternative payment solutions for Chimeric Antigen Receptor T-cell (CAR T) therapy.
AHA's comment on the Centers for Medicare & Medicaid Services’ administrative simplification proposed rule to rescind the adoption of the standard unique Health Plan Identifier (HPID) and Other Entity Identifier (OEID).
AHA's comment on the Centers for Medicare & Medicaid Services’ administrative simplification proposed rule to rescind the adoption of the standard unique Health Plan Identifier (HPID) and Other Entity Identifier (OEID).
AHA comments regarding questions RTI submitted to the participants of the September 2018 technical expert panel on developing a unified post-acute care prospective payment system.